HFrEF in a Younger Cohort: Identifying the Clinical Demographics in Patients With Methamphetamine-Induced Cardiomyopathy

Abstract

Chronic methamphetamine abuse remains a growing cause of dilated cardiomyopathy (MA-CMP) and subsequent heart failure with reduced ejection fraction (HFrEF). However, despite it being increasingly recognised as a disease entity, MA-CMP related HFrEF requires further clinical characterisation.